Health Care & Life Sciences » Biotechnology | Infinity Pharmaceuticals Inc.

Infinity Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
164,995.00
109,066.00
18,723.00
6,000.00
22,146
Cost of Goods Sold (COGS) incl. D&A
1,823.00
-
-
-
-
-
Gross Income
1,823.00
-
-
-
-
-
SG&A Expense
125,853.00
171,145.00
233,882.00
139,912.00
40,730.00
33,884
EBIT
127,676.00
7,923.00
127,108.00
124,607.00
36,445.00
11,929
Unusual Expense
-
-
-
93,716.00
6,882.00
-
Interest Expense
-
9,649.00
1,368.00
1,225.00
1,010.00
93
Pretax Income
126,780.00
17,233.00
128,041.00
30,101.00
42,550.00
11,253
Income Tax
-
183.00
335.00
-
720.00
-
Consolidated Net Income
126,780.00
17,416.00
128,376.00
30,101.00
41,830.00
11,253
Net Income
126,780.00
17,416.00
128,376.00
30,101.00
41,830.00
11,253
Net Income After Extraordinaries
126,780.00
17,416.00
128,376.00
30,101.00
41,830.00
11,253
Net Income Available to Common
126,780.00
17,416.00
128,376.00
30,101.00
41,830.00
11,253
EPS (Basic)
2.64
0.36
2.62
0.61
0.83
0.20
Basic Shares Outstanding
47,936.00
48,561.70
49,083.50
49,608.20
50,560.20
55,411.40
EPS (Diluted)
2.64
0.36
2.62
0.61
0.83
0.20
Diluted Shares Outstanding
47,936.00
48,561.70
49,083.50
49,608.20
50,560.20
55,411.40
EBITDA
125,853.00
6,150.00
124,816.00
121,189.00
34,730.00
11,738
Non-Operating Interest Income
896.00
339.00
435.00
2,015.00
1,787.00
769

About Infinity Pharmaceuticals

View Profile
Address
784 Memorial Drive
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.infi.com
Updated 07/08/2019
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.